ArticleCurrent microbiology2026
Genome-Wide Association of ST, K-, and O-Locus Diversity with Virulence in Indian Klebsiella pneumoniae via Targeted Phenotypic Validation.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Klebsiella pneumoniae is an opportunistic pathogen that causes pneumonia, bacteremia, and urinary tract infections, primarily in healthcare settings. The capsule, lipopolysaccharide, siderophores, and fimbriae are all virulence factors that contribute to its pathogenicity. We leveraged publicly accessible sequence data to outline the distribution of virulence loci; thereafter, nine representative isolates with varied ST-K-O profiles and rmpA/A2 markers underwent targeted phenotypic testing to connect genomic predictions with functional pathogenicity. We conducted an in-depth analysis of the genetic (n = 351) and phenotypic (n = 9) characteristics of Indian isolates, combining 29 of our clinical samples with an extensive dataset from the BV-BRC database. Using modern genomic techniques, we generated the "blueprints" {sequence types and surface antigens (ST-K locus-O locus)} and then validated these results in the lab by looking at different phenotypic traits linked to virulence to see how well the bacteria could survive the immune response. The findings indicated an exceptionally varied environment with 93 distinct sequence types. ST231 and ST14 are the predominant strains in India, frequently associated with the K51 and K64 capsules. Although certain "classic" hypervirulent strains such as ST23 exhibited their vast collection of genes, we observed an unanticipated phenomenon: conventional markers did not consistently align with the actual findings. For example, isolate M58 exhibited remarkable viscosity and mucoid characteristics despite possessing a small capsule, but other isolates with "threatening" genetic profiles were easily eliminated by human serum. Ultimately, our research reveals that virulence is far from a fixed biological constant. Instead, it is a dynamic outcome of specific genomic architectures, proving that no single marker can perfectly predict how dangerous a strain is. This complexity highlights why we must move toward continuous, integrated genomic monitoring to stay one step ahead of these evolving, drug-resistant threats in India.
Indexed as
Identifiers
42012550What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.